Lv1
70 积分 2025-01-30 加入
Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas
6小时前
求助中
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study
10小时前
已完结
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I Study
12小时前
已完结
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
6天前
已完结
Role of poly(ADP-ribose) formation in DNA repair
6天前
已完结
Exploiting metabolic cell death for cancer therapy
8天前
已完结
Decoding ferroptosis for cancer therapy
8天前
已完结
The landscape of regulated cell death: It’s all downhill from here
11天前
已完结
PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells
1个月前
已完结
Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1-Lig3-PARylation complex
1个月前
已完结
皖公网安备34019202002308
